Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report with long term follow-up outcomes.
Robert MahnFarsaneh SadeghlarAlexandra BartelsTaotao ZhouTobias WeismüllerPatrick KupczykCarsten MeyerFlorian C GaertnerMarieta TomaTim VilzPetra KnipperTim GlowkaSteffen ManekellerJörg KalffChristian P StrassburgMaria Angeles Gonzalez-CarmonaPublished in: Medicine (2021)
In conclusion, this report highlights the tolerability and effectiveness of cabozantinib for the treatment of HCC recurrence after LT. We show that our patient with a late recurrence of HCC after LT benefitted from intensive multimodal therapy concepts, including surgery, RFA, and systemic therapy.
Keyphrases
- randomized controlled trial
- minimally invasive
- systematic review
- pain management
- stem cells
- clinical trial
- combination therapy
- case report
- open label
- type diabetes
- acute coronary syndrome
- coronary artery disease
- chronic pain
- coronary artery bypass
- weight loss
- bone marrow
- study protocol
- percutaneous coronary intervention